Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations.
暂无分享，去创建一个
H. Scher | A. Bryce | W. Abida | A. Patnaik | N. Vogelzang | A. Hussain | S. Chowdhury | C. Ryan | D. Despain | I. Percent | D. Petrylak | A. Simmons | Jeremy B. Shapiro | R. J. Amato | R. McDermott | T. Stanton | J. Zhang | M. Collins | T. Golsorskhi